Closing the Research-to-Clinic Gap: Building the Evidence to Translate an Academic Target into RLT Development

• Validating promising academic biology in increasingly translational models to establish whether the target is robust enough for drug development
• Identifying the critical experiments that increased or challenged confidence to determine when continued investment was justified
• Bridging academic discovery & industry validation requirements to build an evidence package capable of progressing a novel target towards the clinic

Novel Target

Speakers:

Shadi Esfahanai

Professor of Radiology, Director of Molecular Theranostics Laboratory

Harvard Medical School